Cancer false alarm may give false sense of security
the ONA take:
According to a new study published in the journal BMJ Open, Cancer Research UK researchers have found that having a cancer false alarm could dissuade people from further investigating cancer symptoms they may develop in the future.
Researchers from the Health Behaviour Research Centre at University College London in United Kingdom conducted a review of 19 international studies to assess the effect of a cancer false alarm.
They found that patients may delay seeking help from a healthcare professional for new or recurrent symptoms if they feel that it is not cancer because of a previous false alarm or if they feel unsupported by the healthcare system.
Researchers found that if patients felt unsupported previously, there is a concern that the healthcare professional will think the patient is making a fuss out of nothing.
Results also showed that insufficient education at the time of the cancer false alarm made the patients feel like the doctor would not be able to help at the time of new onset of symptoms.
The findings suggest that patients should not have a false sense of security after experiencing a cancer false alarm, and that patients should still seek help from a healthcare professional if the experience new or recurrent symptoms.
Having a cancer false alarm could dissuade people from further investigating cancer symptoms they may develop in the future.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- CTCs Promising as Biomarker to Identify Lung Cancer Recurrence
- Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer
- Social Functioning Scores for Young Cancer Survivors Remain Lower Than Their Peers
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
- Survey Reveals Research Priorities for Cancer Patients, Oncology Nurses
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|